The Daily Populous

Tuesday June 7th, 2022 evening edition

image for Russian oligarch Roman Abramovich's British telecoms company Truphone, once worth half a billion dollars, to be sold for $1

Roman Abramovich's Truphone is being sold for about $1 to two European entrepreneurs, a report says.

The company had been worth $512 million in 2020, according to The Times.

A British telecoms company owned by Roman Abramovich is being sold to two European tech entrepreneurs for about $1, The Times reported.

Truphone, valued at $512 million ($410 million) in 2020, has received almost $375 million of investment from Abramovich and two business partners, Alexander Abramov and Alexander Frolov.

Truphone hired the advisory firm FRP in April to review its "strategic options" following the sanctions imposed on the former owner of Chelsea FC.

The $5.3 billion deal was finalised last month to a group led by LA Dodgers co-owner Todd Boehly and the investment firm Clearlake.

Abramovich was once one of Russia's richest oligarchs , worth an estimated $14 billion, but his wealth has nearly halved due to western sanctions. »

PAC Sparks Complaints For Handing Out $25 Gas Vouchers While Campaigning For Herschel Walker

Authored by
image for

We’re gonna do this free gas giveaway for the community,’” Angela Stanton King said.

The state’s voting law even bans volunteers from handing out water to voters while they’re waiting in line at the polls.

Handing out free gas cards to customers, which they say are a gift from Herschel Walker. — Ron Filipkowski 🇺🇦 (@RonFilipkowski) June 4, 2022. »

"First Time In History": Cancer Vanishes For Every Patient In Drug Trial

Authored by
image for

A small group of people with rectal cancer just experienced something of a miracle as their cancer simply vanished after an experimental treatment.

All 18 rectal cancer patients were given the same drug and as a result of the treatment, cancer was completely obliterated in every patient - undetectable by physical exam; endoscopy; positron emission tomography or PET scans or MRI scans.

He even noted that it was especially impressive as not all of the patients suffered significant complications from the trial drug. »

Beyond Weapons: Time for a New U.S. Strategy on Taiwan

Authored by

Biden administration myopia is missing critical opportunities to strengthen not just Taiwan, but the entire Indo-Pacific’s resistance to Chinese belligerence.

For the United States, implementing more effective deterrence for Taiwan is not simply a tactical case study.

Taiwan is not some isolated problem, but a strategically critical component of an Indo-Pacific, indeed global, counter-China strategy. »